Who owns Cumberland Pharmaceuticals?

Key details on Cumberland Pharmaceuticals (Ticker: CPIX)

Who owns Cumberland Pharmaceuticals?

Is CPIX a good stock to own? Find out who bought Cumberland Pharmaceuticals, who sold Cumberland Pharmaceuticals (CPIX) stock, and who holds a large position in Cumberland Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Ariel Investments 1.76M $7.97M Sept. 30, 2013
Frontier Capital Management 759104 $3.19M Dec. 31, 2012
DIMENSIONAL FUND ADVISORS 729006 $3.73M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 603596 $3.08M Dec. 31, 2013
Kestrel Investment Management Corporation 577339 $2.95M Dec. 31, 2013
Millennium Management 500000 $3.75M March 31, 2012
New York State Common Retirement Fund 298172 $1.52M Dec. 31, 2013
Vanguard 267832 $1.37M Dec. 31, 2013
G. W. Henssler & Associates 207904 $1.06M Dec. 31, 2013
United Capital Financial Advisers 197646 $1.01M Dec. 31, 2013
Renaissance Technologies 177662 $804808 Sept. 30, 2013
Heather K. Mellem, Esq. 172394 $724054 Dec. 31, 2012
STATE STREET CORPORATION 149277 $626963 Dec. 31, 2013
BlackRock 132563 $600510 Sept. 30, 2013
NORTHERN TRUST 115997 $586944 June 30, 2013
Perritt Capital Management 111350 $568998 Dec. 31, 2013
LSV Asset Management 100200 $512022 Dec. 31, 2013
MORGAN STANLEY 90680 $453400 Dec. 31, 2013
Bard Associates 89953 $459659 Dec. 31, 2013
Arlington Partners 87795 $437219 March 31, 2013
HighTower Advisors 75577 $386198 June 30, 2013
Bridgeway Capital Management 66400 $278880 Dec. 31, 2012
Berkshire Asset Management 64888 $349097 Dec. 31, 2011
MENTA CAPITAL 63706 $317255 March 31, 2013
GOLDMAN SACHS 59071 $268182 Sept. 30, 2013
Inves 58420 $299110 Dec. 31, 2013
GSA Capital Partners 55695 $285158 Dec. 31, 2013
CalPERS 53800 $239948 March 31, 2014
BlackRock Advisors 53691 $243220 Sept. 30, 2013
Two Sigma Investments 53347 $265134 March 31, 2013
TIAA-CREF Investment Management 50374 $250862 March 31, 2013
Sophrosyne Capital 49000 $206780 Dec. 31, 2012
Sunrise Partners Limited Partnership 47979 $245172 June 30, 2013
Raymond James & Associates 47366 $242040 June 30, 2013

Who sold Cumberland Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Bank of America Corporation Sept. 30, 2012 84827 $547982
HARRIS FINANCIAL Sept. 30, 2011 53070 $296130
Baker Bros. Advisors June 30, 2011 96381 $554190
Barclays June 30, 2011 50515 $289450
VAN DEN BERG MANAGEMENT INC/TX March 31, 2011 72915 $403219
Parametric Portfolio Associates March 31, 2011 64011 $353980
Alerus Financial, N.A. March 31, 2011 54500 $300840
Perceptive Advisors March 31, 2011 50000 $277000
Atlantic Investment Company Dec. 31, 2010 175337 $1.05M